The RalB small GTpase mediates formation of invadopodia through a GTpase-activating protein-independent function of the RalBP1/ RLIP76 effector

Molecular and Cellular Biology

Volumn 32, Issue 8, 2012, Pages 1374-1386

  Neel, Nicole F ^a   Rossman, Kent L ^a,b   Martin, Timothy D ^a,b   Hayes, Tikvah K ^a   Yeh, Jen Jen ^a,b   Der, Channing J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXOCYST; GELATINASE A; GELATINASE B; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; K RAS PROTEIN; MELATONIN 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; RAC1 PROTEIN; RAF PROTEIN; RAL PROTEIN; RAS RELATED PROTEIN RAL B; RHO FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOCHEMISTRY; CANCER INVASION; CELL ACTIVITY; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; HETEROZYGOSITY; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; INVADOPODIA; METASTASIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SEQUENCE; SIGNAL TRANSDUCTION;

ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL SURFACE EXTENSIONS; ENZYME ACTIVATION; GTPASE-ACTIVATING PROTEINS; HUMANS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RAL GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84861322358     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06291-11     Document Type: Article

References (71)

1. Awasthi S, et al. 2000. Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry 39: 9327-9334.
2. Awasthi S, et al. 2001. Functional reassembly of ATP-dependent xenobiotic transport by the N-and C-terminal domains of RLIP76 and identification of ATP binding sequences. Biochemistry 40:4159-4168.
3. Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. 2003. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int. J. Cancer 106:635-646.
4. Baines AT, et al. 2006. Use of retrovirus expression of interfering RNA to determine the contribution of activated K-Ras and ras effector expression to human tumor cell growth. Methods Enzymol. 407:556-574.
5. Barbie DA, et al. 2009. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108-112.
6. Bodemann BO, et al. 2011. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 144:253-267.
7. Bodemann BO, White MA. 2008. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer 8:133-140.
8. Boissel L, et al. 2007. Recruitment of Cdc42 through the GAP domain of RLIP participates in remodeling of the actin cytoskeleton and is involved in Xenopus gastrulation. Dev. Biol. 312:331-343.
9. Brummelkamp TR, Bernards R, Agami R. 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243-247.
10. Buccione R, Caldieri G, Ayala I. 2009. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 28:137-149.
11. Buccione R, Orth JD, McNiven MA. 2004. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 5:647-657.
12. Campbell PM, Der CJ. 2004. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin. Cancer Biol. 14:105-114.
13. Campbell PM, et al. 2007. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res. 67:2098-2106.
14. Cantor SB, Urano T, Feig LA. 1995. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol. Cell. Biol. 15:4578-4584.
15. Cascone I, et al. 2008. Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs. EMBO J. 27:2375-2387.
16. Chen W-T, Yunyon Y, Nakahara H. 1994. An in vitro cell invasion assay: determination of cell surface proteolytic activity that degrades extracellular matrix. J. Tissue Cult. Methods 16:177-181.
17. Chien Y, et al. 2006. RalB GTPase-mediated activation of the I_B family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127:157-170.
18. Cox AD, Der CJ. 2010. Ras history: The saga continues. Small Gtpases 1:2-27.
19. Destaing O, Block MR, Planus E, Albiges-Rizo C. 2011. Invadosome regulation by adhesion signaling. Curr. Opin. Cell Biol. 23:597-606.
20. Fenwick RB, et al. 2010. The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction. Structure 18:985-995.
21. Gimona M, Buccione R, Courtneidge SA, Linder S. 2008. Assembly and biological role of podosomes and invadopodia. Curr. Opin. Cell Biol. 20: 235-241.
22. Hashimoto S, et al. 2004. Requirement for Arf6 in breast cancer invasive activities. Proc. Natl. Acad. Sci. U. S. A. 101:6647-6652.
23. Hoon DS, et al. 2006. Molecular mechanisms of metastasis. Cancer Metastasis Rev. 25:203-220.
24. Hu Y, Mivechi NF. 2003. HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo. J. Biol. Chem. 278:17299-17306.
25. Ikeda M, Ishida O, Hinoi T, Kishida S, Kikuchi A. 1998. Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral. J. Biol. Chem. 273:814-821.
26. Issaq SH, Lim KH, Counter CM. 2010. Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis. Mol. Cancer Res. 8:223-231.
27. Janku F, et al. 2011. PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. PLoS One 6:e22769.
28. Jones S, et al. 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806.
29. Jullien-Flores V, et al. 1995. Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J. Biol. Chem. 270:22473-22477.
30. Jullien-Flores V, et al. 2000. RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis. J. Cell Sci. 113(Pt 16):2837-2844.
31. Karnoub AE, Weinberg RA. 2008. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 9:517-531.
32. Kuroiwa M, Oneyama C, Nada S, Okada M. 2011. The guanine nucleotide exchange factor Arhgef5 plays crucial roles in Src-induced podosome formation. J. Cell Sci. 124:1726-1738.
33. Lee KM, Nguyen C, Ulrich AB, Pour PM, Ouellette MM. 2003. Immortalization with telomerase of the Nestin-positive cells of the human pancreas. Biochem. Biophys. Res. Commun. 301:1038-1044.
34. Lim KH, et al. 2005. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7:533-545.
35. Lim KH, et al. 2010. Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA. Mol. Cell. Biol. 30:508-523.
36. Lim KH, et al. 2006. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr. Biol. 16:2385-2394.
37. Linder S, Wiesner C, Himmel M. 2011. Degrading devices: invadosomes in proteolytic cell invasion. Annu. Rev. Cell Dev. Biol. 27:185-211.
38. Liu J, Yue P, Artym VV, Mueller SC, Guo W. 2009. The role of the exocyst in matrix metalloproteinase secretion and actin dynamics during tumor cell invadopodia formation. Mol. Biol. Cell 20:3763-3771.
39. Luo J, et al. 2009. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137:835-848.
40. Mandal S, Johnson KR, Wheelock MJ. 2008. TGF-beta induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways. Exp. Cell Res. 314:3478-3493.
41. Martin TD, Samuel JC, Routh ED, Der CJ, Yeh JJ. 2011. Activation and involvement of Ral GTPases in colorectal cancer. Cancer Res. 71:206-215.
42. Matsubara K, Hinoi T, Koyama S, Kikuchi A. 1997. The posttranslational modifications of Ral and Rac1 are important for the action of Ral-binding protein 1, a putative effector protein of Ral. FEBS Lett. 410: 169-174.
43. Matsuo Y, et al. 2009. K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways. Mol. Cancer Res. 7:799-808.
44. Matsuzaki T, et al. 2002. Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway. J. Biol. Chem. 277:19008-19018.
45. Mitin N, et al. 2007. Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression. Nat. Struct. Mol. Biol. 14:814-823.
46. Morinaka K, et al. 1999. Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis. Oncogene 18:5915-5922.
47. Moskalenko S, et al. 2002. The exocyst is a Ral effector complex. Nat. Cell Biol. 4:66-72.
48. Moskalenko S, et al. 2003. Ral GTPases regulate exocyst assembly through dual subunit interactions. J. Biol. Chem. 278:51743-51748.
49. Muralidharan-Chari V, et al. 2009. ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. Cancer Res. 69:2201-2209.
50. Nakahara H, et al. 2003. Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells. Genes Cells 8:1019-1027.
51. Neel NF, et al. 2011. The RalGEF-Ral effector signaling network: the road less traveled for anti-Ras drug discovery. Genes Cancer 2:275-287.
52. Nurnberg A, Kitzing T, Grosse R. 2011. Nucleating actin for invasion. Nat. Rev. Cancer. 11:177-187.
53. Pantel K, Brakenhoff RH. 2004. Dissecting the metastatic cascade. Nat. Rev. Cancer 4:448-456.
54. Park SH, Weinberg RA. 1995. A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene 11:2349-2355.
55. Polzin A, Shipitsin M, Goi T, Feig LA, Turner TJ. 2002. Ral-GTPase influences the regulation of the readily releasable pool of synaptic vesicles. Mol. Cell. Biol. 22:1714-1722.
56. Repasky GA, Chenette EJ, Der CJ. 2004. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends Cell Biol. 14:639-647.
57. Rosse C, L'Hoste S, Offner N, Picard A, Camonis J. 2003. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J. Biol. Chem. 278:30597-30604.
58. Sakurai-Yageta M, et al. 2008. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J. Cell Biol. 181:985-998.
59. Scholl C, et al. 2009. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 137:821-834.
60. Shutes A, Der CJ. 2006. Real-time in vitro measurement of intrinsic and Ras GAP-mediated GTP hydrolysis. Methods Enzymol. 407:9-22.
61. Singh A, et al. 2009. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 15:489-500.
62. Singhal SS, Yadav S, Roth C, Singhal J. 2009. RLIP76: A novel glutathione-conjugate and multi-drug transporter. Biochem. Pharmacol. 77:761-769.
63. Tague SE, Muralidharan V, D'Souza-Schorey C. 2004. ADP-ribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ ERK signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 101:9671-9676.
64. Vigil D, et al. 2010. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms. J. Biol. Chem. 285:34729-34740.
65. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. 2011. Pancreatic cancer. Lancet 378:607-620.
66. Wolf K, Friedl P. 2009. Mapping proteolytic cancer cell-extracellular matrix interfaces. Clin. Exp. Metastasis 26:289-298.
67. Yadav S, et al. 2004. Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses. Biochemistry 43:16243-16253.
68. Yamaguchi A, Urano T, Goi T, Feig LA. 1997. An Eps homology (EH) domain protein that binds to the Ral-GTPase target, RalBP1. J. Biol. Chem. 272:31230-31234.
69. Yamaguchi H, et al. 2005. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol. 168:441-452.
70. Yamaguchi H, et al. 2011. Phosphoinositide 3-kinase signaling pathway mediated by p110alpha regulates invadopodia formation. J. Cell Biol. 193: 1275-1288.
71. Zand TP, Reiner DJ, Der CJ. 2011. Ras effector switching promotes divergent cell fates in C. elegans vulval patterning. Dev. Cell 20:84-96.